We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFLN
6176
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
-46
Closed -$1K
PHIO icon
6177
Phio Pharmaceuticals
PHIO
$12.3M
-48
Closed -$2K
PHVS icon
6178
Pharvaris
PHVS
$2.43B
-12,993
Closed -$146K
PICK icon
6179
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.35B
-111
Closed -$5K
PIIIW icon
6180
P3 Health Partners Inc Warrant
PIIIW
$207K
$0 ﹤0.01%
6
PKB icon
6181
Invesco Building & Construction ETF
PKB
$393M
$0 ﹤0.01%
10
+4
+67% +$178
PL.WS
6182
DELISTED
Planet Labs PBC Warrants
PL.WS
$0 ﹤0.01%
+100
New +$91
PLSE icon
6183
Pulse Biosciences
PLSE
$2.96B
-160
Closed
PRENW
6184
Prenetics Global Ltd Warrant
PRENW
$119K
$0 ﹤0.01%
339
PRPH
6185
DELISTED
ProPhase Labs
PRPH
-593
Closed -$57K
PRSO icon
6186
Peraso
PRSO
$10.7M
-7
Closed
PSCC icon
6187
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$40.9M
-16,977
Closed -$577K
PTLC icon
6188
Pacer Trendpilot US Large Cap ETF
PTLC
$3.37B
-5
Closed
PXH icon
6189
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
-3,028
Closed -$53K
QBTS icon
6190
D-Wave Quantum Inc. Common Stock
QBTS
$7.52B
-10,266
Closed -$14K
QCLR icon
6191
Global X NASDAQ 100 Collar 95-110 ETF
QCLR
$3.38M
-1
Closed
QNCX icon
6192
Quince Therapeutics
QNCX
$30M
0
RCAT icon
6193
Red Cat Holdings
RCAT
$1.52B
$0 ﹤0.01%
+75
New +$86
RCEL icon
6194
Avita Medical
RCEL
$235M
-3,464
Closed -$23K
RCG
6195
RENN Fund
RCG
$20.3M
$0 ﹤0.01%
181
RDCM icon
6196
Radcom
RDCM
$169M
-472
Closed -$5K
RDHL
6197
Redhill Biopharma
RDHL
$3.53M
0
REM icon
6198
iShares Mortgage Real Estate ETF
REM
$538M
-3,502
Closed -$79K
REVB icon
6199
Revelation Biosciences
REVB
$4.42M
0
-$2K
RING icon
6200
iShares MSCI Global Gold Miners ETF
RING
$2.45B
$0 ﹤0.01%
+15
New +$354

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.